Age-dependent sex differences in cardiometabolic risk factors

被引:0
作者
Daria V. Zhernakova
Trishla Sinha
Sergio Andreu-Sánchez
Jelmer R. Prins
Alexander Kurilshikov
Jan-Willem Balder
Serena Sanna
Lude Franke
Jan A. Kuivenhoven
Alexandra Zhernakova
Jingyuan Fu
机构
[1] University Medical Center Groningen,Department of Genetics
[2] University of Groningen,Laboratory of Genomic Diversity, Center for Computer Technologies
[3] ITMO University,Department of Pediatrics
[4] University Medical Center Groningen,Department of Obstetrics and Gynecology
[5] University of Groningen,Division of Heart and Lungs, Department of Cardiology, University Medical Center Utrecht
[6] University Medical Center Groningen,undefined
[7] University of Groningen,undefined
[8] Utrecht University,undefined
[9] Istituto di Ricerca Genetica e Biomedica (IRGB) del Consiglio Nazionale delle Ricerche (CNR),undefined
来源
Nature Cardiovascular Research | 2022年 / 1卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cardiometabolic diseases (CMDs) are a major cause of mortality worldwide, yet men and women present remarkable differences in disease prognosis, onset and manifestation. Here we characterize how sex differences in cardiometabolic risk factors vary with age by examining 45 phenotypes and 6 lifestyle factors in 146,021 participants of the Dutch population cohort Lifelines. We show that sex differences are present in 71% of the studied phenotypes. For 31% of these phenotypes, the phenotypic difference between sexes is dependent on age. CMD risk factors show various patterns of age-related sex differences, ranging from no difference for phenotypes such as body mass index (BMI) to strong age-modified sex differences for lipid levels. We also identify lifestyle factors that influence phenotypes in a sex- and age-dependent manner. These results highlight the importance of taking age into account when studying sex differences in CMDs.
引用
收藏
页码:844 / 854
页数:10
相关论文
共 115 条
  • [1] Zhao M(2016)Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes Eur. Heart J. 37 24-34
  • [2] Millett ERC(2020)Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta‐analysis J. Am. Heart Assoc. 9 e014742-e2726
  • [3] Peters SAE(2018)Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants BMJ 363 k4247-1172
  • [4] Woodward M(2020)Sex differences in the association between major risk factors and the risk of stroke in the UK Biobank cohort study Neurology 95 e2715-1035
  • [5] Peters SAE(1999)Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland Circulation 99 1165-37
  • [6] Carcel C(2019)Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016 Circulation 139 1025-1108
  • [7] Millett ERC(2017)Mechanistic pathways of sex differences in cardiovascular disease Physiol. Rev. 97 1-940
  • [8] Woodward M(2012)The intersection between aging and cardiovascular disease Circ. Res. 110 1097-1064.e6
  • [9] Jousilahti P(2021)Sex differences in biological aging with a focus on human studies eLife 10 e63425-2924
  • [10] Vartiainen E(2014)Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study Brit. Med. J. 349 g5992-1507